Logo BSU

Please use this identifier to cite or link to this item: https://elib.bsu.by/handle/123456789/234273
Title: Synthetic phenolic antioxidant TS-13 suppresses the growth of Lewis lung carcinoma and potentiates oncolytic effect of doxorubicin
Authors: Men’shchikova, E. B.
Zenkov, N. K.
Kozhin, P. M.
Chechushkov, A. V.
Kovner, A. V.
Khrapova, M. V.
Kandalintseva, N. V.
Martinovich, G. G.
Keywords: ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::Физика
Issue Date: 2019
Citation: Bulletin of experimental biology and medicine, 2019, Vol. 166, No. 5, pp. 646-650.
Abstract: ROS are important intracellular messengers; their ambiguous role in malignant processes was demonstrated in many studies. The effects of a synthetic phenolic antioxidant sodium 3-(3’-tert-butyl-4’-hydroxyphenyl)propyl thiosulfonate sodium (TS-13) on the tumor growth and oncolytic properties of doxorubicin were studied in the experimental model of Lewis lung carcinoma in mice. In mice receiving TS-13 with drinking water (100 mg/kg), suppression of tumor growth by 32.3% was observed on day 21 after inoculation of Lewis lung carcinoma cells. Two-fold intraperitoneal injections of doxorubicin in a cumulative dose of 8 mg/kg were followed by inhibition of tumor growth by 49.5%. Combined treatment with TS-13 and doxorubicin suppressed the tumor growth by 55.4%. In contrast to doxorubicin, TS-13 inhibited NO generation by peritoneal macrophages. The results show the prospect of studying TS-13 in the context of overcoming drug-resistance of tumors.
URI: http://elib.bsu.by/handle/123456789/234273
DOI: 10.1007/s10517-019-04410-6
Appears in Collections:Кафедра биофизики

Files in This Item:
File Description SizeFormat 
2019 TS 13 suppresses growth of Lewis lung carcinoma.pdf1,89 MBAdobe PDFView/Open


PlumX

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.